{'fraction_non_alphanumeric': 0.05321100917431193, 'fraction_numerical': 0.06360856269113149, 'mean_word_length': 4.080745341614906, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 3, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Prevalence of Face Mask Wearing in Northern Vermont in Response to the COVID-19 Pandemic

Objectives Information on the prevalence of face mask use to reduce the spread of SARS-CoV-2 is needed to model disease spread and to assess the effectiveness of policies that encourage face mask use. We sought to (1) estimate the prevalence of face mask use in northern Vermont and (2) assess the effect of age and sex on the likelihood of face mask use. Methods We monitored the entrances to public businesses and visually assessed age, sex, and face mask use. We collected 1004 observations during May 16-30, 2020. We calculated estimates of overall face mask use and odds ratios (ORs) for effects by age and sex. Results Of 1004 observations, 758 (75.5%) sampled people used a face mask. Our census-weighted estimate was 74.1%. A higher percentage of females than males wore face masks (83.8% vs 67.6%). The odds of face mask use were lower among males than among females (OR = 0.52; 95% CI, 0.37-0.73). Face mask use generally decreased with decreasing age: 91.4% among adults aged >60, 70.7% among adults aged 26-60, 74.8% among people aged 15-25, and 53.3% among people aged ≤14. The OR of an adult aged >60 wearing a face mask was 14.70 times higher, for young people aged 15-25 was 2.72 times higher, and for adults aged 26-60 was 2.99 times higher than for people aged ≤14. Females aged >60 had the highest percentage of face mask use (96.3%) and males aged ≤14 had the lowest (43.8%). Conclusions Educational efforts promoting the use of face masks should be targeted at males and younger age groups to limit the spread of SARS-CoV-2.